
|Articles|October 1, 2003
Supplements and Featured Publications
- Biopharmaceutical Agents for Treating Rheumatoid Arthritis: Impact on Patients and Managed Care Heal
- Volume 9
- Issue 6 Suppl
Treatment Compliance and Dosage Administration Among Rheumatoid Arthritis Patients Receiving Infliximab, Etanercept, or Methotrexate
Advertisement
Articles in this issue
over 22 years ago
Participating FacultyAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
2
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
3
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
4
Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk
5





